[{"address1": "5217 Winnebago Lane", "city": "Austin", "state": "TX", "zip": "78744", "country": "United States", "phone": "512 386 2900", "website": "https://www.xbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Simard", "age": 62, "title": "Founder, President, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 5556481, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Hu", "age": 40, "title": "Director of Finance", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 198133, "exercisedValue": 0, "unexercisedValue": 1200}, {"maxAge": 1, "name": "Dr. Sushma  Shivaswamy Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 449990, "exercisedValue": 0, "unexercisedValue": 4000}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.01, "open": 4.27, "dayLow": 3.8108, "dayHigh": 4.3, "regularMarketPreviousClose": 4.01, "regularMarketOpen": 4.27, "regularMarketDayLow": 3.8108, "regularMarketDayHigh": 4.3, "exDividendDate": 1626307200, "forwardPE": 29.846155, "volume": 51165, "regularMarketVolume": 51165, "averageVolume": 68514, "averageVolume10days": 82210, "averageDailyVolume10Day": 82210, "bid": 3.8, "ask": 3.99, "bidSize": 100, "askSize": 100, "marketCap": 118275984, "fiftyTwoWeekLow": 3.51, "fiftyTwoWeekHigh": 9.96, "fiftyDayAverage": 6.2831, "twoHundredDayAverage": 6.959375, "currency": "USD", "enterpriseValue": -54842092, "floatShares": 19841393, "sharesOutstanding": 30483500, "sharesShort": 775226, "sharesShortPriorMonth": 848259, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.0254, "heldPercentInsiders": 0.35107, "heldPercentInstitutions": 0.1619, "shortRatio": 12.73, "shortPercentOfFloat": 0.0434, "impliedSharesOutstanding": 31504800, "bookValue": 6.312, "priceToBook": 0.61470217, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -32658000, "trailingEps": -1.08, "forwardEps": 0.13, "enterpriseToEbitda": 1.352, "52WeekChange": -0.259542, "SandP52WeekChange": 0.22263205, "lastDividendValue": 2.5, "lastDividendDate": 1626307200, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "XBIT", "underlyingSymbol": "XBIT", "shortName": "XBiotech Inc.", "longName": "XBiotech Inc.", "firstTradeDateEpochUtc": 1429104600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "fb07a30b-f4ae-35af-9fbb-83dba861caeb", "messageBoardId": "finmb_216818432", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.88, "recommendationKey": "none", "totalCash": 183118000, "totalCashPerShare": 6.007, "ebitda": -40570000, "totalDebt": 10000000, "quickRatio": 11.505, "currentRatio": 11.57, "debtToEquity": 5.205, "returnOnAssets": -0.120349996, "returnOnEquity": -0.15747, "freeCashflow": -22160624, "operatingCashflow": -27856000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]